Aluminum Oxide

證據等級: L4 | 預測適應症: 10


## 藥師評估報告

Aluminum oxide:從胃酸過多到類風濕性關節炎

一句話總結

Aluminum oxide 原本用於緩解胃部不適或灼熱感等胃酸過多症狀。 TxGNN 模型預測它可能對**類風濕性關節炎 (Rheumatoid Arthritis)** 有效, 目前有 **1 個臨床試驗**和 **1 篇文獻**支持這個方向,但證據主要來自於材料科學研究。

快速總覽

項目 內容
原適應症 緩解胃部不適或灼熱感、或經診斷為胃及十二指腸潰瘍、胃炎、食道炎所伴隨之胃酸過多。
預測新適應症 類風濕性關節炎 (Rheumatoid Arthritis)
TxGNN 預測分數 99.98%
證據等級 L4
台灣上市 ✓ 已上市
許可證數 18 張
建議決策 Hold

預測適應症詳細分析

1. rheumatoid arthritis L3 99.98% 主要分析

為什麼這個預測合理?

目前缺乏詳細的作用機轉資料。根據已知資訊,Aluminum oxide 是一種內服凝膠劑,主要用於緩解胃酸過多相關症狀。

由於類風濕性關節炎涉及免疫系統,現有劑型無法達到全身性療效,需開發新劑型以評估其在類風濕性關節炎中的潛力。

</p>

此預測基於藥物的作用機轉,與現有臨床證據方向一致。

臨床試驗

試驗編號階段狀態人數主要發現
NCT00764530NACOMPLETED342Keramos Ceramic/Ceramic Total Hip System

相關文獻

PMID年份類型期刊主要發現
358190692022ArticleACS biomaterials science & engNIR-PTT/ROS-Scavenging/Oxygen-Enriched Synergetic Therapy for Rheumatoid Arthrit...
24097501985ArticleActa medica ScandinavicaPlasma total prekallikrein/kallikrein activity in rheumatoid arthritis with and ...
323421352020ArticleNaunyn-Schmiedeberg's archivesAnti-arthritic and anti- inflammatory effects of extract and fractions of Malva ...
49500061970ArticleProgress in clinical pathologyAntibodies to tissues.
355495912022ArticleJournal of drug targetingZIF-8 nanoparticles coated with macrophage-derived microvesicles for sustained, ...
327078852020ArticleMolecules (Basel, Switzerland)Benzylideneacetophenone Derivative Alleviates Arthritic Symptoms via Modulation ...
72587471981ArticleAnnals of allergyEvaluation of lymphocyte populations and their mitogenic activity in relation to...
300629382018ArticleThe bone & joint journalMid-term results of alumina ceramic unlinked total elbow arthroplasty with cemen...
43651751974ArticlePolish journal of pharmacologyProstaglandins and inflammation.
289586582018ArticleThe Journal of arthroplastyA Minimum Ten Years of Follow-Up of Alumina Head on Delta Liner Total Hip Arthro...
28380051988ArticleArchives of pathology & laboraDiseases associated with exposure to silica and nonfibrous silicate minerals. Si...
122116912002ArticleThe Journal of bone and joint Effects of alumina and zirconium dioxide particles on arachidonic acid metabolis...
241970592014ArticleJournal of orthopaedic scienceA 5-22-year follow-up study of stemmed alumina ceramic total elbow arthroplastie...
282380092017ArticleActa medica OkayamaResults of Total Elbow Arthroplasty with Cementless Implantation of an Alumina C...
139224801962ArticleReumatismo[The bentonite flocculation test in rheumatoid arthritis and in other morbid con...
56831631968ArticleExperientiaHageman factor (factor XII) activity in synovial fluid of rheumatoid arthritis p...
69873121980ArticleJournal of immunological methoQuantitative determination of rheumatoid factor by an enzyme-labeled immunoassay...
320976982020ArticleJournal of ethnopharmacologyEffect of phenolic compounds from Oenothera rosea on the kaolin-carrageenan indu...
252609802014ArticleArthritis research & therapyTapping into the endocannabinoid system to ameliorate acute inflammatory flares ...
136269761959ArticleThe American journal of the meA comparison of the latex fixation-whole serum, latex fixation-euglobulin fracti...
</details>
2. brachydactyly-syndactyly syndrome L5 99.96%
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果,需進一步驗證。
3. colobomatous microphthalmia-rhizomelic dysplasia syndrome L5 99.96%
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果,需進一步驗證。
4. heparin cofactor 2 deficiency L4 99.90%

相關文獻(1 篇)

PMID年份類型期刊主要發現
38383151985ArticleThe Journal of biological chemThe protease specificity of heparin cofactor II. Inhibition of thrombin generate...
5. hemoglobinopathy L4 99.90%

相關文獻(1 篇)

PMID年份類型期刊主要發現
379518562023ArticleBMC oral healthEffects of different removal methods of excess resin adhesive on the microleakag...
6. factor 5 excess with spontaneous thrombosis L5 99.90%
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果,需進一步驗證。
7. antithrombin deficiency type 2 L5 99.89%
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果,需進一步驗證。
8. thrombotic disease L4 99.87%

相關文獻(20 篇)

PMID年份類型期刊主要發現
395800782025ArticleJournal of controlled release Macrophage membrane-encapsulated miRNA nanodelivery system for the treatment of ...
383967282024ArticleInternational journal of molecThrombelastography and Conventional Coagulation Markers in Chronic Obstructive P...
234292522013ArticleBlood coagulation & fibrinolysC-reactive protein and fibrin clot strength measured by thrombelastography after...
95649041998ArticleThe Annals of thoracic surgeryPathogenesis of systemic air embolism during bronchoscopic Nd:YAG laser operatio...
201545372010ArticleThe Journal of traumaSafety evaluation of new hemostatic agents, smectite granules, and kaolin-coated...
88504701996ArticleLasers in surgery and medicinePhotodynamic therapy (PDT) of the ciliary body with silicon naphthalocyanine (SI...
96032851998ArticleLasers in surgery and medicineAcute results, complications, and effect of lesion characteristics on outcome wi...
100640021999ArticleThrombosis and haemostasisdRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activi...
14662711992ArticleAgents and actions. SupplementA finding of highly selective synthetic inhibitor of plasma kallikrein; its acti...
239442732013ArticleVeterinary clinical pathologyEndogenous fibrinolytic potential in tissue-plasminogen activator-modified throm...
128429922003ArticleBloodThe mutation Ser511Asn leads to N-glycosylation and increases the cleavage of hi...
6984021978ArticleBloodCoupled amidolytic assay for factor VII: its use with a clotting assay to determ...
94906821998ArticleBloodDifferential effects of anti-beta2-glycoprotein I and antiprothrombin antibodies...
74199601980ArticleThe Journal of laboratory and Rapid fibrinolysis, augmented Hageman factor (factor XII) titers, and decreased ...
68035701982ArticleAmerican journal of clinical pPrekallikrein inhibition associated with the lupus anticoagulant: a mechanism of...
42368241968ArticleThrombosis et diathesis haemorRelease of platelet factor 4 in vivo during intravascular coagulation and in thr...
1280181975ArticlePhysiologia BohemoslovacaA quantitative model of venous stasis thrombosis in rats.
67411451984ArticleWiener klinische Wochenschrift[The PTFE plastic prosthesis as an arterial replacement: experiences over a 5-ye...
12268141975ArticleZeitschrift fur Allgemeinmediz[Therapy of chronic persistent ulcus cruris with phlebostatic edema in chronic p...
44602111974ArticleRevue roumaine de medecine (19Clotting disturbances as thrombosis risk factors. Significance and diagnostic va...
9. beta-thalassemia with other manifestations L5 99.85%
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果,需進一步驗證。
10. hemolytic anemia due to glucophosphate isomerase deficiency L5 99.84%
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果,需進一步驗證。
## 台灣上市資訊 | 許可證號 | 品名 | 劑型 | 核准適應症 | |---------|------|------|-----------| | 內衛藥製字第009846號 | "人人"氫氧化鋁凝膠 | 內服凝膠劑 | 緩解胃部不適或灼熱感、或經診斷為胃及十二指腸潰瘍、胃炎、食道炎所伴隨之胃酸過多。 | ## 安全性考量 安全性資訊請參考原廠仿單。 ## 結論與下一步 **決策:Hold** **理由:** 目前的證據主要來自於材料科學研究,缺乏直接的臨床療效證據,且現有劑型不適用於全身性療效。 **若要推進需要:** - 詳細的藥物作用機轉資料(MOA) - 針對類風濕性關節炎的直接臨床試驗 - 開發適合全身性療效的新劑型 --- ## 相關藥物報告 - [Ritonavir](/drugs/ritonavir/) - 證據等級 L4 - [Salicylamide](/drugs/salicylamide/) - 證據等級 L4 - [Hydroquinone](/drugs/hydroquinone/) - 證據等級 L4 - [Brodalumab](/drugs/brodalumab/) - 證據等級 L4 - [Acebutolol](/drugs/acebutolol/) - 證據等級 L4 ---
用 AI 幫我深入分析

想進一步了解這個藥物的老藥新用潛力嗎?點擊下方按鈕,直接開啟 AI 助手進行分析。

Claude:點擊後會複製提問並開啟新視窗,請按 Ctrl+V(Mac: Cmd+V)貼上
ChatGPT:點擊後直接開啟並自動帶入提問

## 引用本報告 如需引用本報告,請使用以下格式: **APA 格式:** ``` TwTxGNN. (2026). Aluminum Oxide老藥新用驗證報告. https://twtxgnn.yao.care/drugs/aluminum_oxide/ ``` **BibTeX 格式:** ```bibtex @misc{twtxgnn_aluminum_oxide, title = {Aluminum Oxide老藥新用驗證報告}, author = {TwTxGNN Team}, year = {2026}, url = {https://twtxgnn.yao.care/drugs/aluminum_oxide/} } ``` ---
免責聲明
本報告僅供學術研究參考,不構成醫療建議。藥物使用請遵循醫師指示,切勿自行調整用藥。任何老藥新用決策需經過完整的臨床驗證與法規審查。

最後審核:2026-02-20 | 審核者:TwTxGNN Research Team

討論與回饋

歡迎分享您對本報告的看法、補充資訊或提出問題。討論內容會同步到 GitHub Discussions。 需要 GitHub 帳號才能留言。


回到頂部

Copyright © 2026 Yao.Care. 本報告僅供研究參考,不構成醫療建議。

This site uses Just the Docs, a documentation theme for Jekyll.